Duncan McKechnie, EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,541 shares at $519.00 ($800K) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Scheduled sale ($800k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2026-02-26 | $2.4M | — | Filing → |